Myelodysplastic syndrome risk factors: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Nawal Muazam (talk | contribs)
nocaptcha
1,911 edits
No edit summary
Nawal Muazam (talk | contribs)
nocaptcha
1,911 edits
No edit summary
Line 3: Line 3:
{{CMG}};{{AE}}{{NM}}
{{CMG}};{{AE}}{{NM}}
==Overview==
==Overview==
Common risk factors in the development of myelodysplastic syndrome are tobacco smoke, ionizing radiation, organic chemicals, and heavy metals.<ref name=cancergov>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq#link/_570_toc. Accessed on December 7, 2015</ref>
Common risk factors in the development of myelodysplastic syndrome are past treatment with [[chemotherapy]], [[radiation therapy]], past exposure to [[tobacco smoke]], [[ionizing radiation]], [[organic chemicals]], and [[heavy metals]].<ref name=cancergov>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq#link/_570_toc. Accessed on December 7, 2015</ref>
==Myelodysplastic syndrome risk factors==
==Myelodysplastic syndrome risk factors==
Common risk factors in the development of myelodysplastic syndrome are:<ref name=cancergov>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq#link/_570_toc. Accessed on December 7, 2015</ref>
Common risk factors in the development of myelodysplastic syndrome are:<ref name=cancergov>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq#link/_570_toc. Accessed on December 7, 2015</ref>
Line 15: Line 15:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
*Chemotherapy
*[[Chemotherapy]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
*Radiation therapy
*[[Radiation therapy]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; text-align:Center;"|
| style="padding: 5px 5px; background: #DCDCDC; text-align:Center;"|
Line 24: Line 24:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
*Tobacco smoke
*[[Tobacco smoke]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
*Ionizing radiation
*[[Ionizing radiation]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
*Organic chemicals
*[[Organic chemicals]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
*Herbicides
*[[Herbicides]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
*Pesticides
*[[Pesticides]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|
| style="padding: 5px 5px; background: #F5F5F5; text-align:left;"|

Revision as of 04:20, 14 December 2015

Myelodysplastic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelodysplastic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelodysplastic syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelodysplastic syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelodysplastic syndrome risk factors

CDC on Myelodysplastic syndrome risk factors

Myelodysplastic syndrome risk factors in the news

Blogs on Myelodysplastic syndrome risk factors

Directions to Hospitals Treating Myelodysplastic syndrome

Risk calculators and risk factors for Myelodysplastic syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Common risk factors in the development of myelodysplastic syndrome are past treatment with chemotherapy, radiation therapy, past exposure to tobacco smoke, ionizing radiation, organic chemicals, and heavy metals.[1]

Myelodysplastic syndrome risk factors

Common risk factors in the development of myelodysplastic syndrome are:[1]

Risk Factors

Past Treatment

Past Exposure

  • Fertilizers
  • Stone and cereal dusts
  • Exhaust gases
  • Nitro-organic explosives
  • Petroleum and diesel derivatives

References

  1. ↑ 1.0 1.1 Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq#link/_570_toc. Accessed on December 7, 2015


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Myelodysplastic_syndrome_risk_factors&oldid=1194356"